Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Pro-Dex, Inc.

PDEXNASDAQ
Healthcare
Medical - Instruments & Supplies
$39.00
$0.00(0.00%)
U.S. Market is Open • 12:46

Pro-Dex, Inc. Fundamental Analysis

Pro-Dex, Inc. (PDEX) shows strong financial fundamentals with a PE ratio of 11.32, profit margin of 15.73%, and ROE of 29.25%. The company generates $0.1B in annual revenue with strong year-over-year growth of 23.68%.

Key Strengths

ROE29.25%
Current Ratio4.03

Areas of Concern

PEG Ratio9.71
We analyze PDEX's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 81.8/100 based on profitability, valuation, growth, and balance sheet metrics. The B+ grade reflects solid fundamentals with room for improvement in valuation or growth.

Fundamental Health Score

B+
81.8/100

We analyze PDEX's fundamental strength across five key dimensions:

Efficiency Score

Excellent

PDEX demonstrates superior asset utilization.

ROA > 10%
18.21%

Valuation Score

Moderate

PDEX shows balanced valuation metrics.

PE < 25
11.32
PEG Ratio < 2
9.71

Growth Score

Moderate

PDEX shows steady but slowing expansion.

Revenue Growth > 5%
23.68%
EPS Growth > 10%
3.48%

Financial Health Score

Excellent

PDEX maintains a strong and stable balance sheet.

Debt/Equity < 1
0.28
Current Ratio > 1
4.03

Profitability Score

Excellent

PDEX achieves industry-leading margins.

ROE > 15%
29.25%
Net Margin ≥ 15%
15.73%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is PDEX Expensive or Cheap?

P/E Ratio

PDEX trades at 11.32 times earnings. This suggests potential undervaluation.

11.32

PEG Ratio

When adjusting for growth, PDEX's PEG of 9.71 indicates potential overvaluation.

9.71

Price to Book

The market values Pro-Dex, Inc. at 3.08 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

3.08

EV/EBITDA

Enterprise value stands at 7.20 times EBITDA. This is generally considered low.

7.20

How Well Does PDEX Make Money?

Net Profit Margin

For every $100 in sales, Pro-Dex, Inc. keeps $15.73 as profit after all expenses.

15.73%

Operating Margin

Core operations generate 15.74 in profit for every $100 in revenue, before interest and taxes.

15.74%

ROE

Management delivers $29.25 in profit for every $100 of shareholder equity.

29.25%

ROA

Pro-Dex, Inc. generates $18.21 in profit for every $100 in assets, demonstrating efficient asset deployment.

18.21%

Following the Money - Real Cash Generation

Operating Cash Flow

Pro-Dex, Inc. generates limited operating cash flow of $6.49M, signaling weaker underlying cash strength.

$6.49M

Free Cash Flow

Pro-Dex, Inc. produces free cash flow of $6.14M, offering steady but limited capital for shareholder returns and expansion.

$6.14M

FCF Per Share

Each share generates $1.88 in free cash annually.

$1.88

FCF Yield

PDEX converts 4.76% of its market value into free cash.

4.76%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

11.32

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

9.71

vs 25 benchmark

P/B Ratio

Price to book value ratio

3.08

vs 25 benchmark

P/S Ratio

Price to sales ratio

1.79

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.28

vs 25 benchmark

Current Ratio

Current assets to current liabilities

4.03

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.29

vs 25 benchmark

ROA

Return on assets percentage

0.18

vs 25 benchmark

ROCE

Return on capital employed

0.23

vs 25 benchmark

How PDEX Stacks Against Its Sector Peers

MetricPDEX ValueSector AveragePerformance
P/E Ratio11.3229.43 Better (Cheaper)
ROE29.25%800.00% Weak
Net Margin15.73%-20145.00% (disorted) Strong
Debt/Equity0.280.30 Neutral
Current Ratio4.034.64 Strong Liquidity
ROA18.21%-17936.00% (disorted) Strong

PDEX outperforms its industry in 4 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Pro-Dex, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

127.40%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

74.73%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

-133.93%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ